Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models
Introduction: Taohong Siwu Decoction (TSD) is a traditional Chinese medicine used to treat cardiovascular diseases and blood stasis. This study explores the therapeutic mechanisms of TSD in treating hyperlipidemia using a network pharmacology approach combined with a zebrafish hyperlipidemia model....
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Pharmacological Research - Modern Chinese Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667142525000296 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849334786152202240 |
|---|---|
| author | Mingyang Li Xinmei Zhang Chunyue Bao Fan Li Yulong Wu Guangming Huo Chuanfeng Tang Jianmei Li |
| author_facet | Mingyang Li Xinmei Zhang Chunyue Bao Fan Li Yulong Wu Guangming Huo Chuanfeng Tang Jianmei Li |
| author_sort | Mingyang Li |
| collection | DOAJ |
| description | Introduction: Taohong Siwu Decoction (TSD) is a traditional Chinese medicine used to treat cardiovascular diseases and blood stasis. This study explores the therapeutic mechanisms of TSD in treating hyperlipidemia using a network pharmacology approach combined with a zebrafish hyperlipidemia model. Methods: Compounds in TSD were sourced from a database and filtered based on oral bioavailability and drug-likeness. Herbal targets were predicted using online tools, and hyperlipidemia-related genes were identified via GeneCards. Pathway analysis was conducted to pinpoint relevant signaling pathways. Molecular docking, performed with AutoDock, assessed the binding affinity of key compounds to target proteins. In vivo experiments using zebrafish models evaluated the anti-hyperlipidemic, anti-inflammatory, and antioxidant effects of TSD, with RT-qPCR used to verify the expression of predicted targets. Results: Network pharmacology analysis revealed 45 bioactive phytochemicals and 72 potential target genes implicated in hyperlipidemia-related pathways. Six principal bioactive compounds—quercetin, luteolin, myricanone, stigmasterol, kaempferol, and β-sitosterol—were identified as modulators of core therapeutic targets including TNF, IL6, IL1B, PTGS2, PPARG, ESR1, PTGS1, and PIK3CG, influencing critical pathways associated with inflammatory responses, oxidative stress modulation, and lipid metabolism regulation. Molecular docking analysis demonstrated robust binding affinities between these compounds and their respective targets, particularly PTGS2 and PIK3CG. Zebrafish experiments substantiated TSD's therapeutic efficacy in ameliorating hyperlipidemia, attenuating inflammation, and mitigating oxidative stress, thereby validating the predicted mechanisms of action. Discussion/Conclusions: TSD exhibits a characteristic multi-component, multi-target, and multi-pathway therapeutic profile in the management of hyperlipidemia and associated atherosclerotic conditions. These findings support its clinical application and provide a theoretical basis for future research. |
| format | Article |
| id | doaj-art-9c511da60d484caaa048cd46eb9520e9 |
| institution | Kabale University |
| issn | 2667-1425 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Pharmacological Research - Modern Chinese Medicine |
| spelling | doaj-art-9c511da60d484caaa048cd46eb9520e92025-08-20T03:45:28ZengElsevierPharmacological Research - Modern Chinese Medicine2667-14252025-06-011510060010.1016/j.prmcm.2025.100600Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish modelsMingyang Li0Xinmei Zhang1Chunyue Bao2Fan Li3Yulong Wu4Guangming Huo5Chuanfeng Tang6Jianmei Li7School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, ChinaSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, ChinaSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, ChinaSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, ChinaSchool of Food Science, Nanjing Xiaozhuang University, Nanjing 211171, ChinaSchool of Food Science, Nanjing Xiaozhuang University, Nanjing 211171, ChinaState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing 210023, China; Corresponding authors.School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China; Corresponding authors.Introduction: Taohong Siwu Decoction (TSD) is a traditional Chinese medicine used to treat cardiovascular diseases and blood stasis. This study explores the therapeutic mechanisms of TSD in treating hyperlipidemia using a network pharmacology approach combined with a zebrafish hyperlipidemia model. Methods: Compounds in TSD were sourced from a database and filtered based on oral bioavailability and drug-likeness. Herbal targets were predicted using online tools, and hyperlipidemia-related genes were identified via GeneCards. Pathway analysis was conducted to pinpoint relevant signaling pathways. Molecular docking, performed with AutoDock, assessed the binding affinity of key compounds to target proteins. In vivo experiments using zebrafish models evaluated the anti-hyperlipidemic, anti-inflammatory, and antioxidant effects of TSD, with RT-qPCR used to verify the expression of predicted targets. Results: Network pharmacology analysis revealed 45 bioactive phytochemicals and 72 potential target genes implicated in hyperlipidemia-related pathways. Six principal bioactive compounds—quercetin, luteolin, myricanone, stigmasterol, kaempferol, and β-sitosterol—were identified as modulators of core therapeutic targets including TNF, IL6, IL1B, PTGS2, PPARG, ESR1, PTGS1, and PIK3CG, influencing critical pathways associated with inflammatory responses, oxidative stress modulation, and lipid metabolism regulation. Molecular docking analysis demonstrated robust binding affinities between these compounds and their respective targets, particularly PTGS2 and PIK3CG. Zebrafish experiments substantiated TSD's therapeutic efficacy in ameliorating hyperlipidemia, attenuating inflammation, and mitigating oxidative stress, thereby validating the predicted mechanisms of action. Discussion/Conclusions: TSD exhibits a characteristic multi-component, multi-target, and multi-pathway therapeutic profile in the management of hyperlipidemia and associated atherosclerotic conditions. These findings support its clinical application and provide a theoretical basis for future research.http://www.sciencedirect.com/science/article/pii/S2667142525000296Taohong Siwu decoctionHyperlipidemiaNetwork pharmacologyZebrafish models |
| spellingShingle | Mingyang Li Xinmei Zhang Chunyue Bao Fan Li Yulong Wu Guangming Huo Chuanfeng Tang Jianmei Li Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models Pharmacological Research - Modern Chinese Medicine Taohong Siwu decoction Hyperlipidemia Network pharmacology Zebrafish models |
| title | Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models |
| title_full | Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models |
| title_fullStr | Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models |
| title_full_unstemmed | Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models |
| title_short | Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models |
| title_sort | exploring the mechanism of taohong siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models |
| topic | Taohong Siwu decoction Hyperlipidemia Network pharmacology Zebrafish models |
| url | http://www.sciencedirect.com/science/article/pii/S2667142525000296 |
| work_keys_str_mv | AT mingyangli exploringthemechanismoftaohongsiwudecoctioninthetreatmentofhyperlipidemiabasedonnetworkpharmacologyandzebrafishmodels AT xinmeizhang exploringthemechanismoftaohongsiwudecoctioninthetreatmentofhyperlipidemiabasedonnetworkpharmacologyandzebrafishmodels AT chunyuebao exploringthemechanismoftaohongsiwudecoctioninthetreatmentofhyperlipidemiabasedonnetworkpharmacologyandzebrafishmodels AT fanli exploringthemechanismoftaohongsiwudecoctioninthetreatmentofhyperlipidemiabasedonnetworkpharmacologyandzebrafishmodels AT yulongwu exploringthemechanismoftaohongsiwudecoctioninthetreatmentofhyperlipidemiabasedonnetworkpharmacologyandzebrafishmodels AT guangminghuo exploringthemechanismoftaohongsiwudecoctioninthetreatmentofhyperlipidemiabasedonnetworkpharmacologyandzebrafishmodels AT chuanfengtang exploringthemechanismoftaohongsiwudecoctioninthetreatmentofhyperlipidemiabasedonnetworkpharmacologyandzebrafishmodels AT jianmeili exploringthemechanismoftaohongsiwudecoctioninthetreatmentofhyperlipidemiabasedonnetworkpharmacologyandzebrafishmodels |